ARCHIVES

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 25 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Guideline Aims To Improve Hormone Receptor Testing

April 23, 2010

“Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.”

July 7, 1995

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989